Company Overview of Altheos, Inc.
Altheos, Inc., an early-stage biopharmaceutical company, engages in the identification and development of small molecule drugs for the treatment of glaucoma and ocular hypertension. It develops ATS907 and ATS8535, a selective Rho kinase inhibitor for treatment of elevated intraocular pressure associated with glaucoma. The company was founded in 2009 and is based in South San Francisco, California.
601 Gateway Boulevard
South San Francisco, CA 94080
Founded in 2009
Key Executives for Altheos, Inc.
Similar Private Companies By Industry
|TwoF, Inc.||United States|
|Elusys Therapeutics, Inc.||United States|
|Celexion, LLC||United States|
|SphynKx Therapeutics LLC||United States|
|DTI Medical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Altheos, Inc., please visit www.altheos.net. Company data is provided by Capital IQ. Please use this form to report any data issues.